跳至主要内容
临床试验/ACTRN12617001326381
ACTRN12617001326381已完成2 期

Effects of noradrenergic and antimuscarinic agents on obstructive sleep apnoea (OSA) severity and upper airway muscle activity during sleep in OSA

euroscience Research Australia (NeuRA)0 个研究点目标入组 15 人开始时间: 2017年9月15日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Otherwise healthy men and women with obstructive sleep apnoea aged 18-65 years

排除标准

  • -Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
  • -Patients with any other medical condition which may interfere in the evaluation of the study.
  • -Patients with a previous history of addiction to alcohol or drugs.
  • -Patients taking medications known to affect sleep or muscle activity.

研究者

发起方
euroscience Research Australia (NeuRA)

相似试验